Impact of more detailed categorization of shrinkage or progression ratio at initial imaging response after sorafenib treatment in advanced hepatocellular carcinoma patients

BACKGROUND: Sorafenib therapy improves survival in unresectable hepatocellular carcinoma (HCC) patients without an objective response. The present study investigated whether the initial imaging response might be a prognostic indicator after administration of sorafenib therapy in HCC patients. PATIEN...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: Wada, Yoshiyuki, Takami, Yuko, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Saitsu, Hideki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636094/
https://ncbi.nlm.nih.gov/pubmed/26586953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S94246
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi